Improving the efficacy and reducing the side effects of drug therapy will be a boon to doctors, patients, and insurance companies, to be sure, but why should pharmaceutical companies embrace personalized medicine in the long term?
毫无疑问，增进药效、减少副作用对医生、病患和保险公司都是好事，但为什么从长期看制药公司也应该接受个性化疗法呢？